• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2-丙炔基吡咯烷衍生物的化学和生物化学研究。N-甲基-N-(1-甲基-4-吡咯烷基-2-丁炔基)乙酰胺(BM-5)的受限旋转类似物。

Chemical and biochemical studies of 2-propynylpyrrolidine derivatives. Restricted-rotation analogues of N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide (BM-5).

作者信息

Trybulski E J, Kramss R H, Mangano R M, Rusinko A

机构信息

American Cyanamid Company, Lederle Laboratories, Pearl River, New York 10965.

出版信息

J Med Chem. 1990 Dec;33(12):3190-8. doi: 10.1021/jm00174a015.

DOI:10.1021/jm00174a015
PMID:2258905
Abstract

A series of optically pure 2-[substituted-3-aminopropynyl]pyrrolidine derivatives, which are restricted-rotation analogues of the muscarinic agent N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide (BM-5, compound 1), have been prepared from d- and l-proline. The compounds when tested in a series of in vitro muscarinic assays [[3H]CD (cortex), [3H]QNB (cortex), [3H]PZ (cortex), [3H]QNB (heart), [3H]QNB + GppNHp (heart)] were found to have weaker muscarinic properties than compound 1. The decrease in affinity was attributed to the increased size of the molecule resulting from the addition of a methylene group to form the pyrrolidine ring. The use of optically active compounds provided a more detailed examination of the complex pharmacological effects of the flexible muscarinic agent 1. The R enantiomers in the acetamide derivatives 12b, 12d, and 12f had a 5-10-fold greater affinity for the muscarinic receptor than the corresponding S enantiomers. A 5-fold difference or less found in the (R)- and (S)-carbamate derivatives 9, 15, and 16 suggested close overlap of the two enantiomers in the receptor binding domain. The affinity differences found in the enantiomeric acetamido derivatives when compared to those of the carbamate analogues may be the result of limited rotation of the acetamido group.

摘要

一系列光学纯的2-[取代-3-氨基丙炔基]吡咯烷衍生物,它们是毒蕈碱剂N-甲基-N-(1-甲基-4-吡咯烷基-2-丁炔基)乙酰胺(BM-5,化合物1)的限制旋转类似物,已由d-和l-脯氨酸制备而成。在一系列体外毒蕈碱测定中([³H]CD(皮质)、[³H]QNB(皮质)、[³H]PZ(皮质)、[³H]QNB(心脏)、[³H]QNB + GppNHp(心脏))对这些化合物进行测试时,发现它们的毒蕈碱特性比化合物1弱。亲和力的降低归因于分子因添加亚甲基形成吡咯烷环而增大。使用光学活性化合物对柔性毒蕈碱剂1的复杂药理作用进行了更详细的研究。乙酰胺衍生物12b、12d和12f中的R对映体对毒蕈碱受体的亲和力比相应的S对映体高5至10倍。在(R)-和(S)-氨基甲酸酯衍生物9、15和16中发现的5倍或更小的差异表明两种对映体在受体结合域中紧密重叠。与氨基甲酸酯类似物相比,在对映体乙酰胺衍生物中发现的亲和力差异可能是乙酰胺基团旋转受限的结果。

相似文献

1
Chemical and biochemical studies of 2-propynylpyrrolidine derivatives. Restricted-rotation analogues of N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide (BM-5).2-丙炔基吡咯烷衍生物的化学和生物化学研究。N-甲基-N-(1-甲基-4-吡咯烷基-2-丁炔基)乙酰胺(BM-5)的受限旋转类似物。
J Med Chem. 1990 Dec;33(12):3190-8. doi: 10.1021/jm00174a015.
2
Resolved pyrrolidine, piperidine, and perhydroazepine analogues of the muscarinic agent N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide.毒蕈碱剂N-甲基-N-(1-甲基-4-吡咯烷基-2-丁炔基)乙酰胺的吡咯烷、哌啶和全氢氮杂卓类似物。
J Med Chem. 1990 Dec;33(12):3182-9. doi: 10.1021/jm00174a014.
3
Urea and 2-imidazolidone derivatives of the muscarinic agents oxotremorine and N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide.毒蕈碱类药物氧化震颤素和N-甲基-N-(1-甲基-4-吡咯烷基-2-丁炔基)乙酰胺的尿素和2-咪唑烷酮衍生物。
J Med Chem. 1992 Aug 21;35(17):3270-9. doi: 10.1021/jm00095a025.
4
Conformationally restricted analogues of the muscarinic agent N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide.毒蕈碱剂N-甲基-N-(1-甲基-4-吡咯烷基-2-丁炔基)乙酰胺的构象受限类似物。
J Med Chem. 1989 Apr;32(4):863-9. doi: 10.1021/jm00124a022.
5
[3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.[3H]哌仑西平和(-)-[3H]奎宁环基苯甲酸酯与大鼠大脑皮质和心脏毒蕈碱胆碱能位点的结合。I. 激动剂与假定毒蕈碱亚型结合的特性及调节
J Pharmacol Exp Ther. 1986 May;237(2):411-8.
6
[3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.[3H]哌仑西平和(-)-[3H]东莨菪碱与大鼠大脑皮质及心脏毒蕈碱胆碱能位点的结合。II. 拮抗剂与假定毒蕈碱亚型结合的特性及调节
J Pharmacol Exp Ther. 1986 May;237(2):419-27.
7
Amide, urea, and carbamate analogues of the muscarinic agent [4-[[N-(3-chlorophenyl)carbamoyl]oxy]-2-butynyl]trimethylammonium chloride.毒蕈碱剂[4-[[N-(3-氯苯基)氨基甲酰基]氧基]-2-丁炔基]三甲基氯化铵的酰胺、脲和氨基甲酸酯类似物。
J Med Chem. 1992 Jul 24;35(15):2787-98. doi: 10.1021/jm00093a011.
8
Binding studies with [3H]cis-methyldioxolane in different tissues. Under certain conditions [3H]cis-methyldioxolane labels preferentially but not exclusively agonist high affinity states of muscarinic M2 receptors.
Naunyn Schmiedebergs Arch Pharmacol. 1987 Apr;335(4):372-7. doi: 10.1007/BF00165550.
9
Pharmacological differences between the high-affinity muscarinic agonist binding states of the rat heart and cerebral cortex labeled with (+)-[3H]cismethyldioxolane.
J Pharmacol Exp Ther. 1984 Jun;229(3):747-55.
10
Characterization of high affinity [3H]pirenzepine and (-)-[3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rabbit peripheral lung.高亲和力[3H]哌仑西平和(-)-[3H]东莨菪碱与兔外周肺毒蕈碱胆碱能受体结合的特性研究
J Pharmacol Exp Ther. 1987 Jan;240(1):51-8.